US 6723721
CRF receptor antagonists and methods relating thereto
expired A61PA61P1/00A61P1/14
Quick answer
US patent 6723721 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61P, A61P1/00, A61P1/14, A61P25/00, A61P25/08